In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Grandparents Raising Grandchildren 
Assistance Act of 1993''.

SEC. 2. FINDINGS.

    The Congress finds that--
            (1) many grandparents throughout the United States are the 
        primary caregivers to their grandchildren and such grandparents 
        are essentially starting over as parents;
            (2) grandparents are acting as parents for a second time 
        primarily because of problems relating to the natural parents 
        of their grandchildren such as drug and alcohol addiction, 
        abuse, divorce, AIDS and other health problems, and teenage 
        pregnancy;
            (3) grandparents and the grandchildren for whom they 
        provide care often suffer legal, financial, emotional, and 
        bureaucratic hardships; and
            (4) it is desirable to develop national policies that 
        assist grandparents who are serving as the primary caregivers 
        to their grandchildren.

SEC. 3. GRANDCHILD SOCIAL SECURITY BENEFITS BASED ONLY ON DEPENDENCY.

    (a) In General.--Subsection (e) of section 216 of the Social 
Security Act (42 U.S.C. 416) is amended--
            (1) by striking ``, but only if'' in the first sentence and 
        all that follows through ``such individual died''; and
            (2) by striking the last sentence.
    (b) Additional Requirements if Parents Are Alive.--Section 
202(d)(9) of the Social Security Act (42 U.S.C. 402(d)(9)) is amended 
by adding at the end the following new subparagraph:
    ``(C) If--
            ``(i) a child is treated as a child of an individual under 
        clause (3) of the first sentence of section 216(e), and
            ``(ii) a natural or adoptive parent of the child is living 
        at the time specified in paragraph (1)(C) of this subsection,
such child shall not be treated as dependent on such individual as of 
such time unless the period described in subparagraphs (A) and (B) is 
two years, and the natural or adoptive parent, if over the age of 18 
years, is not a dependent for whom a deduction is allowable under 
section 151 of the Internal Revenue Code of 1986 to such individual.''.
    (c) Suspension of Benefits if Child Reunites With Parents.--Section 
202(d)(1) of the Social Security Act (42 U.S.C. 402(d)(1)) is amended--
            (1) by striking ``or'' at the end of subparagraph (F);
            (2) by striking the period at the end of subparagraph (G) 
        and inserting ``; or''; and
            (3) by inserting after subparagraph (G) the following new 
        subparagraph:
            ``(H) in the case of a child described in paragraph (9)(C), 
        the first month during which such child lives with such child's 
        natural or adoptive parent who has attained the age of 18 and 
        who is not a dependent as described in such paragraph.''.
    (d) Effective Date.--The amendments made by this section shall 
apply to benefits payable for months after the date of the enactment of 
this Act, but only on the basis of applications filed after such date.

SEC. 4. DEVELOPMENT OF OPTIONAL MODEL PROCEDURE FOR NOTIFYING RELATIVES 
              PRIOR TO PLACEMENT OF A CHILD IN FOSTER CARE.

    (a) In General.--Part E of title IV of the Social Security Act (42 
U.S.C. 670 et seq.) is amended by inserting after section 477 the 
following new section:

   ``development of model procedure for notifying relatives prior to 
                  placement of a child in foster care

    ``Sec. 478. Not later than 180 days after the date of the enactment 
of this section, the Secretary shall develop a model procedure to be 
used by any State with a plan approved under this part which ensures 
that reasonable efforts will be made prior to the placement of a child 
in foster care to give notice to a relative (including a maternal or 
fraternal grandparent, adult sibling, aunt, or uncle) who might be 
available to care for the child.''.
    (b) State Option to Establish Model Procedure.--Subsection (a) of 
section 471 of the Social Security Act (42 U.S.C. 671) is amended--
            (1) by striking ``and'' at the end of paragraph (16);
            (2) by striking the period at the end of paragraph (17) and 
        inserting ``; and''; and
            (3) by adding at the end the following new paragraph:
            ``(18) at the option of the State, provides that the State 
        agency will establish the procedure developed by the Secretary 
        under section 478 or an alternate procedure for notifying 
        relatives prior to the placement of a child in foster care.''.
    (c) Effective Date.--The amendments made by this section shall be 
effective on the date of the enactment of this Act.

SEC. 5. MODEL STANDARDS FOR INSURANCE COVERAGE OF DEPENDENTS.

    (a) Development of Model Standards.--If, within 1-year after the 
date of the enactment of this section, the National Association of 
Insurance Commissioners has not developed model standards for the 
coverage of dependents under health insurance policies, the Secretary 
of Health and Human Services (hereafter in this section referred to as 
the ``Secretary''), shall develop such standards not later than 180 
days after the end of such 1-year period.
    (b) Distribution of Model Standards.--If the Secretary develops 
model standards under subsection (a), the Secretary shall distribute 
such standards to the commissioner of insurance, or any similar 
official, of each State.

SEC. 6. CENSUS DATA ON GRANDPARENTS AS PRIMARY CAREGIVERS FOR THEIR 
              GRANDCHILDREN.

    (a) In General.--Not later than 90 days after the date of the 
enactment of this section, the Secretary of Commerce (hereafter in this 
section referred to as the ``Secretary''), in carrying out the 
provisions of section 141 of title 13, United States Code, shall expand 
the data collection efforts of the Bureau of the Census (hereafter in 
this section referred to as the ``Bureau'') to enable the Bureau to 
collect statistically significant data, in connection with its 
decennial census and its mid-decade census, concerning the growing 
trend of grandparents who are the primary caregivers for their 
grandchildren.
    (b) Expanded Census Question.--In carrying out the provisions of 
subsection (a), the Secretary shall expand the Bureau's census question 
that details households which include both grandparents and their 
grandchildren. The expanded question shall be formulated to distinguish 
between the following households:
            (1) a household in which a grandparent temporarily provides 
        a home for a grandchild for a period of weeks or months during 
        periods of parental distress; and
            (2) a household in which a grandparent provides a home for 
        a grandchild and serves as the primary caregiver for the 
        grandchild.

SEC. 7. GRANTS FOR THE ESTABLISHMENT AND OPERATION OF A NATIONAL 
              RESOURCE CENTER FOR GRANDPARENTS.

    (a) In General.--Section 202 of the Older Americans Act of 1965 (42 
U.S.C. 3012) is amended by adding at the end the following:
    ``(f)(1) The Commissioner shall make grants to, or enter into 
contracts with, one eligible entity to establish and operate the 
National Resource Center for Grandparents (referred to in this 
subsection as the `Center') to serve as a central source of information 
and assistance to older individuals who--
            ``(A) raise their grandchildren;
            ``(B) encounter problems obtaining access to their 
        grandchildren for purposes of visitation; or
            ``(C) need financial, legal, emotional, or informational 
        assistance regarding their relationship with their 
        grandchildren.
    ``(2) The Center shall--
            ``(A) be staffed by employees and volunteers, including 
        such older individuals;
            ``(B) provide a toll-free telephone number to increase 
        access to the information and assistance available from the 
        Center;
            ``(C) collect and make available to such older individuals 
        information regarding programs, projects, and activities of 
        public and private entities (including governmental entities) 
        relating to the matters described in subparagraphs (A), (B), 
        and (C) of paragraph (1), including information on State law 
        regarding grandparent visitation and Federal assistance 
        available to such older individuals; and
            ``(D) refer individual grandparents to public and private 
        entities that provide information or assistance regarding the 
        rearing of grandchildren, including information regarding the 
        prevention of drug abuse and the promotion of good health and 
        nutrition.
    ``(3) For purposes of this subsection, the term `eligible entity' 
means a nonprofit private organization with a demonstrated record of 
experience in representing the concerns of older individuals with 
respect to their relationship to their grandchildren.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect on the first day of the first fiscal year beginning after 
the date of the enactment of this Act.
Example Output: Grandparents Raising Grandchildren Assistance Act of 1993 - Amends title II (Old Age, Survivors and Disability Insurance) (OASDI) of the Social Security Act (SSA) to qualify grandchildren for social security benefits based only on their dependency on social security recipients. Sets special rules if one of a grandchild's natural or adoptive parents is living.  Provides for suspension of such benefits in the event the grandchild reunites with a natural or adoptive parent. 
Amends part E (Foster Care and Adoption Assistance) of SSA title IV to direct the Secretary of Health and Human Services to develop a model procedure for States to use in notifying relatives before the placement of a child in foster care. 
Directs the Secretary, if the National Association of Insurance Commissioners (NAIC) has not done so by a specified deadline, to develop model standards for the coverage of dependents under health insurance policies. 
Requires the Secretary of Commerce to expand the data collection efforts of the Bureau of the Census to enable it to collect statistically significant data on the growing trend of grandparents who are the primary caregivers for their grandchildren. 
Amends the Older Americans Act of 1965 to direct the Commissioner on Aging to make grants to or enter contracts with one eligible entity to establish and operate the National Resource Center for Grandparents to serve as a central source of information and assistance to older individuals who:  (1) raise their grandchildren; (2) encounter problems obtaining visitation access to their grandchildren; or (3) need financial, legal, emotional, or informational assistance regarding their relationship with their grandchildren.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Helping Effective Antibiotics Last 
Act of 2015'' or the ``HEAL Act''.

SEC. 2. APPROVAL OF CERTAIN DRUGS FOR USE IN A WELL-DEFINED POPULATION 
              OF PATIENTS.

    (a) Approval of Certain Antibacterial.--Section 505 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at 
the end the following:
    ``(x) Approval of Certain Antibacterial Drugs for Use in a Well-
Defined Population of Patients.--
            ``(1) Unmet medical need defined.--In this subsection, the 
        term `unmet medical need' means that the antibacterial drug 
        involved--
                    ``(A) has improved efficacy, as demonstrated in 
                adequate, well-controlled studies in humans, for 
                specific diseases or conditions, where current 
                therapies have been shown to be less effective;
                    ``(B) has clinically meaningful decreased harms, 
                demonstrated in adequate, well-controlled studies in 
                humans, for diseases or conditions, where current 
                therapies have unacceptable adverse effects; or
                    ``(C) has improved convenience, as demonstrated in 
                adequate, well-controlled studies in humans, where 
                improved convenience results in improved effectiveness 
                or decreased harms.
            ``(2) Approval.--Upon receipt of an application under 
        subsection (b) for an antibacterial drug that is intended to 
        treat a serious or life-threatening disease or condition, 
        irrespective of whether the drug is intended to address an 
        unmet medical need, the Secretary--
                    ``(A) may approve the drug under subsection (c) 
                only for treating a well-defined population of 
                patients, and based upon the results of clinical trials 
                inclusive of human subjects representative of such 
                well-defined population;
                    ``(B) in determining whether to grant such 
                approval, shall rely on superior outcomes over 
                available therapies based on direct measures of patient 
                benefits, as demonstrated in adequate, well-controlled 
                studies in the well-defined patient population, such 
                as--
                            ``(i) decreased mortality;
                            ``(ii) irreversible morbidity; or
                            ``(iii) validated surrogate endpoints that 
                        reflect mortality or irreversible morbidity; 
                        and
                    ``(C) shall require the labeling of drugs approved 
                pursuant to this subsection to prominently include in 
                the prescribing information required by section 201.57 
                of title 21, Code of Federal Regulations (or any 
                successor regulation)--
                            ``(i) the population of patients with 
                        respect to which the added benefit over 
                        available therapies is expected as studied in 
                        adequate, well-controlled studies that form the 
                        basis for approval; and
                            ``(ii) the method for identifying members 
                        of that population.
            ``(3) Risk evaluation and mitigation strategy.--The 
        Secretary--
                    ``(A) shall require a risk evaluation and 
                mitigation strategy (REMS) under section 505-1 for each 
                drug approved under this subsection; and
                    ``(B) may include in any such strategy additional 
                elements to assure the safe use of the drug under 
                subsections (e) and (f) of section 505-1.
            ``(4) Rule of construction.--Nothing in this subsection 
        shall be construed to alter the standards of evidence under 
        subsection (c) or (d) (including the substantial evidence 
        standard in subsection (d)). Subsections (c) and (d) and such 
        standards of evidence apply to the review and approval of drugs 
        under this subsection, including whether a drug is safe and 
        effective. Nothing in this subsection shall be construed to 
        limit the authority of the Secretary to approve products 
        pursuant to this Act and the Public Health Service Act as 
        authorized prior to the date of enactment of this subsection.
            ``(5) Effective immediately.--The Secretary shall have the 
        authorities vested in the Secretary by this subsection 
        beginning on the date of enactment of this subsection, 
        irrespective of when and whether the Secretary promulgates 
        final regulations to carry out this subsection.''.
    (b) Licensure of Certain Biological Products.--Section 351(j) of 
the Public Health Service Act (42 U.S.C. 262(j)) is amended--
            (1) by striking ``(j)'' and inserting ``(j)(1)'';
            (2) by inserting ``505(x),'' after ``505(p),''; and
            (3) by adding at the end the following:
    ``(2) In applying section 505(x) of the Federal Food, Drug, and 
Cosmetic Act to the licensure of biological products under this 
section--
            ``(A) references to an antibacterial drug with added 
        benefits over available therapies for a well-defined population 
        that is intended to treat a serious or life-threatening disease 
        or condition shall be construed to refer to biological products 
        with added benefits over available therapies for a well-defined 
        population intended to treat a bacterial infection associated 
        with a serious or life-threatening disease; and
            ``(B) references to an application submitted under section 
        505(b) of such Act and to approval of a drug under section 
        505(c) of such Act shall be construed to refer to an 
        application submitted under subsection (a) of this section and 
        to licensure of a biological product under such subsection (a), 
        respectively.''.
    (c) Monitoring.--Title III of the Public Health Service Act is 
amended by inserting after section 317T (42 U.S.C. 247b-22) the 
following:

``SEC. 317U. MONITORING OF ANTIBACTERIAL DRUG USE, PATIENT OUTCOMES, 
              AND RESISTANCE.

    ``(a) Monitoring.--The Secretary, acting through the Director of 
the Centers for Disease Control and Prevention, shall use the National 
Healthcare Safety Network or another appropriate monitoring system to 
monitor--
            ``(1) changes in patient outcomes such as mortality and 
        irreversible morbidity causally related to antibacterial 
        resistance; and
            ``(2) changes in bacterial resistance to drugs in relation 
        to patient outcomes.
    ``(b) Public Availability of Data.--The Secretary, acting through 
the Director of the Centers for Disease Control and Prevention, shall 
make the data derived from monitoring under this section publicly 
available for the purposes of--
            ``(1) improving the monitoring of important trends in 
        patient outcomes in relation to antibacterial resistance; and
            ``(2) ensuring appropriate stewardship of antibacterial 
        drugs, including those receiving approval or licensure for a 
        well-defined population pursuant to section 505(x) of the 
        Federal Food, Drug, and Cosmetic Act.''.

SEC. 3. SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROBIAL 
              ORGANISMS.

    (a) In General.--Section 511 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360a) is amended to read as follows:

``SEC. 511. SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROBIAL 
              ORGANISMS.

    ``(a) In General.--The Secretary shall--
            ``(1) identify upon approval or licensing of antibacterial 
        drugs (including biological products intended to treat a 
        bacterial infection and other types of antimicrobial drugs, as 
        deemed appropriate by the Secretary), including qualified 
        infectious disease products, susceptibility test interpretive 
        criteria for such drugs based upon patient outcomes of 
        mortality and morbidity from adequate and well-controlled 
        studies and such other confirmatory evidence as the Secretary 
        deems necessary; and
            ``(2) update, consistent with subsection (b), such criteria 
        as needed based upon scientific evidence of changes in patient 
        outcomes.
    ``(b) Responding to Changes in Patient Outcomes To Evaluate 
Susceptibility Test Interpretive Criteria.--
            ``(1) In general.--As needed based on evidence related to 
        changes in patient outcomes, the Secretary shall--
                    ``(A) evaluate any new scientific studies on 
                changes in patient outcomes in relation to 
                susceptibility test interpretive criteria; and
                    ``(B) publish on the public Website of the Food and 
                Drug Administration a notice--
                            ``(i) presenting suggested new or updated 
                        interpretive criteria; and
                            ``(ii) if needed, hold a public advisory 
                        committee to discuss scientific evidence 
                        related to changes in interpretative criteria.
            ``(2) Annual compilation of notices.--Each year, the 
        Secretary shall compile the notices published under paragraph 
        (1)(B) noting any changes from prior notices and publish such 
        compilation in the Federal Register.
    ``(c) Definition.--In this section, the term `susceptibility test 
interpretive criteria' means one or more specific values which 
characterize patient outcomes in relation to the degree to which 
bacteria or other microbes are more resistant to treatment as measured 
by patient outcomes.''.
    (b) Conforming Amendment.--Section 1111 of the Food and Drug 
Administration Amendments Act of 2007 (42 U.S.C. 247d-5a; relating to 
identification of clinically susceptible concentrations of 
antimicrobials) is repealed.
    (c) Report to Congress.--Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services shall 
submit to the Committee on Energy and Commerce of the House of 
Representatives and the Committee on Health, Education, Labor, and 
Pensions of the Senate a report on the progress made in implementing 
section 511 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360a), as amended by this section.

SEC. 4. REQUIRING DEMONSTRATION OF SUPERIOR OUTCOMES FOR QUALIFIED 
              INFECTIOUS DISEASE PRODUCTS TO RECEIVE AN EXTENDED 
              EXCLUSIVITY PERIOD.

    Section 505E(g) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355f(g)) is amended by striking ``means an antibacterial or 
antifungal drug for human use intended to treat'' and inserting ``means 
an antibacterial or antifungal drug for human use that is demonstrated 
to produce superior outcomes over available therapies, based on direct 
measures of patient benefits in clinical trials, and that is intended 
to treat''.

SEC. 5. GUIDANCE ON TARGET PRODUCT PROFILES.

    Not later than 18 months after the date of enactment of this Act, 
the Commissioner of Food and Drugs, in consultation with the 
Administrator of the Centers for Medicare & Medicaid Services, the 
Director of the Indian Health Service, the Secretary of Defense, and 
the Secretary of Veterans Affairs, shall issue guidance on the 
development of target product profiles for novel antibacterial drugs 
focused on public health priorities.
Example Output: Helping Effective Antibiotics Last Act of 2015 or the HEAL Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve an antibacterial drug or biological product that is intended to treat a serious or life-threatening condition only for treating a well-defined population of patients. To be approved, the antibacterial product must produce superior outcomes over available therapies in the well-defined patient population. A product approved by this pathway must include in its prescribing information the population of patients expected to benefit from using the product and the method for identifying members of that population. The FDA must require each product to have a risk evaluation and mitigation strategy. The Centers for Disease Control and Prevention must monitor changes to bacterial drug resistance and changes to patient outcomes caused by bacterial drug resistance. Upon approval of antibacterial products, the FDA must identify susceptibility test interpretive criteria (the drug concentrations where a type of bacteria is categorized as susceptible, intermediate, or resistant) and update the criteria as needed based upon evidence of changes in patient outcomes.  To be eligible for an exclusivity period extension, a qualified infectious disease product must be demonstrated to produce superior outcomes over available therapies. The FDA must issue guidance on the development of target product profiles for antibacterial drugs.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``North Korean Enablers Accountability 
Act of 2017''.

SEC. 2. FINDINGS.

    Congress makes the following findings:
            (1) The Government of the Democratic People's Republic of 
        Korea has flagrantly defied the international community by 
        illicitly developing its nuclear and ballistic missile 
        programs, in violation of United Nations Security Council 
        Resolutions 1718 (2006), 1874 (2009), 2087 (2013), 2094 (2013), 
        2270 (2016), and 2321 (2016).
            (2) The Government of the Democratic People's Republic of 
        Korea engages in gross human rights abuses against its own 
        people and citizens of other countries, including the United 
        States and Japan.
            (3) The United States and its partners are committed to 
        pursuing a peaceful denuclearization of the Democratic People's 
        Republic of Korea through a policy of maximum pressure and 
        engagement.

SEC. 3. SANCTIONS WITH RESPECT TO THE GOVERNMENT OF THE DEMOCRATIC 
              PEOPLE'S REPUBLIC OF KOREA AND ITS ENABLERS.

    (a) Blocking of Property.--On and after the date that is 90 days 
after the date of the enactment of this Act, the President shall block 
and prohibit all transactions in all property and interests in property 
of a person described in subsection (d) if such property and interests 
in property are in the United States, come within the United States, or 
are or come within the possession or control of a United States person.
    (b) Facilitation of Certain Transactions.--The President shall 
prohibit the opening, and prohibit or impose strict conditions on the 
maintaining, in the United States of a correspondent account or a 
payable-through account by a foreign financial institution that the 
President determines has knowingly, on or after the date that is 90 
days after the date of the enactment of this Act, conducted or 
facilitated a significant transaction with respect to the importation, 
sale, or transfer of goods or services from the Democratic People's 
Republic of Korea on behalf of a person described in subsection (d).
    (c) Importation, Sale, or Transfer of Goods and Services.--The 
President shall impose sanctions pursuant to the International 
Emergency Economic Powers Act (50 U.S.C. 1701 et seq.) with respect to 
a person if the President determines that the person knowingly, on or 
after the date that is 90 days after the date of the enactment of this 
Act, imports, purchases, or transfers goods or services from a person 
described in subsection (d).
    (d) Persons Described.--A person described in this subsection is 
any of the following:
            (1) The Government of the Democratic People's Republic of 
        Korea or any political subdivision, agency, or instrumentality 
        of that Government.
            (2) Any person owned or controlled, directly or indirectly, 
        by that Government.
            (3) Any person acting or purporting to act, directly or 
        indirectly, for or on behalf of that Government.
            (4) The following entities:
                    (A) Dandong Zhicheng Metallic Material.
                    (B) Shandong International Trade co Ltd Hongjian.
                    (C) Xiamen Xiang Yu Shares Co.
                    (D) Sdic Jingmin Putian Ltd.
                    (E) Hangzhou Pei Amoy Trading company.
                    (F) Hunchun xin Times.
                    (G) Rizhao Steel Holding.
                    (H) Shandong Yun Hill Mines.
                    (I) China Dawn Garmet (Dalian).
                    (J) Dandong Hao Du Trading co. ltd.
            (5) Any person affiliated with an entity described in 
        paragraph (4).
            (6) Any person affiliated with an entity identified by the 
        Secretary of the Treasury as a major importer of goods and 
        services from the Democratic People's Republic of Korea.
    (e) Exemptions.--The following activities are exempt from sanctions 
under this section:
            (1) Activities subject to the reporting requirements under 
        title V of the National Security Act of 1947 (50 U.S.C. 3091 et 
        seq.).
            (2) Authorized intelligence activities of the United 
        States.
            (3) Activities necessary to comply with United States 
        obligations under the Agreement between the United Nations and 
        the United States of America regarding the Headquarters of the 
        United Nations, signed at Lake Success June 26, 1947, and 
        entered into force November 21, 1947, the Convention on 
        Consular Relations, done at Vienna April 24, 1963, and entered 
        into force March 19, 1967, or any other international 
        agreement.
            (4) Activities incidental to the POW/MIA accounting mission 
        in the Democratic People's Republic of Korea, including 
        activities by the Defense POW/MIA Accounting Agency and other 
        governmental or nongovernmental organizations tasked with 
        identifying or recovering the remains of members of the United 
        States Armed Forces in the Democratic People's Republic of 
        Korea.
    (f) Waivers.--
            (1) In general.--The President may waive the application of 
        sanctions under this section with respect to a person if the 
        President--
                    (A) determines that the waiver is in the national 
                security interest of the United States; and
                    (B) submits to the appropriate congressional 
                committees a report on the determination and the 
                reasons for the determination.
            (2) Humanitarian waiver.--
                    (A) In general.--The President may waive, for 
                renewable periods of not less than 30 days and not more 
                than one year, the application of sanctions under this 
                section if the President submits to the appropriate 
                congressional committees a written determination that 
                the waiver is necessary for humanitarian assistance or 
                to carry out the humanitarian purposes set forth in 
                section 4 of the North Korean Human Rights Act of 2004 
                (22 U.S.C. 7802).
                    (B) Content of written determination.--A written 
                determination submitted under subparagraph (A) with 
                respect to a waiver shall include a description of all 
                notification and accountability controls that have been 
                employed in order to ensure that the activities covered 
                by the waiver are humanitarian assistance or are 
                carried out for the purposes set forth in section 4 of 
                the North Korean Human Rights Act of 2004 (22 U.S.C. 
                7802) and do not entail any activities in North Korea 
                or dealings with the Government of North Korea not 
                reasonably related to humanitarian assistance or those 
                purposes.
                    (C) Clarification of permitted activities.--An 
                internationally recognized humanitarian organization 
                shall not be subject to sanctions under this section 
                for--
                            (i) engaging in a financial transaction 
                        relating to humanitarian assistance or for 
                        humanitarian purposes pursuant to a waiver 
                        issued under subparagraph (A);
                            (ii) transporting goods or services that 
                        are necessary to carry out operations relating 
                        to humanitarian assistance or humanitarian 
                        purposes pursuant to such a waiver; or
                            (iii) having merely incidental contact, in 
                        the course of providing humanitarian assistance 
                        or aid for humanitarian purposes pursuant to 
                        such a waiver, with individuals who are under 
                        the control of a foreign person subject to 
                        sanctions under this section.
    (g) Rule of Construction.--A person described in subsection (d) is 
subject to sanctions under this section without regard to whether the 
name of the person is published in the Federal Register or incorporated 
into the list of specially designated nationals and blocked persons 
maintained by the Office of Foreign Assets Control of the Department of 
the Treasury.
    (h) Definitions.--In this section:
            (1) Appropriate congressional committees.--The term 
        ``appropriate congressional committees'' means--
                    (A) the Committee on Foreign Relations and the 
                Committee on Banking, Housing, and Urban Affairs of the 
                Senate; and
                    (B) the Committee on Foreign Affairs and the 
                Committee on Financial Services of the House of 
                Representatives.
            (2) Correspondent account; payable-through account.--The 
        terms ``correspondent account'' and ``payable-through account'' 
        have the meanings given those terms in section 5318A of title 
        31, United States Code.
            (3) Foreign financial institution.--The term ``foreign 
        financial institution'' has the meaning given that term in 
        section 561.308 of title 31, Code of Federal Regulations (or 
        any corresponding similar regulation or ruling).
            (4) Humanitarian assistance.--The term ``humanitarian 
        assistance'' means assistance to meet humanitarian needs, 
        including needs for food, medicine, medical supplies, clothing, 
        and shelter.
            (5) Knowingly.--The term ``knowingly'', with respect to 
        conduct, a circumstance, or a result, means that a person has 
        actual knowledge, or should have known, of the conduct, the 
        circumstance, or the result.
            (6) United states person.--The term ``United States 
        person'' means--
                    (A) a United States citizen or an alien lawfully 
                admitted for permanent residence to the United States; 
                and
                    (B) an entity organized under the laws of the 
                United States or any jurisdiction within the United 
                States, including a foreign branch of such an entity.

SEC. 4. PROHIBITION ON IMPORT OF AND SANCTIONS WITH RESPECT TO GOODS 
              MADE WITH NORTH KOREAN LABOR.

    (a) Prohibition on Import of Goods Made With North Korean Labor.--
            (1) In general.--Except as provided in paragraph (2), any 
        significant goods, wares, articles, or merchandise mined, 
        produced, or manufactured wholly or in part by the labor of 
        nationals or citizens of the Democratic People's Republic of 
        Korea shall be deemed to be mined, produced, or manufactured, 
        as the case may be, by convict labor, forced labor, or 
        indentured labor under penal sanctions for purposes of section 
        307 of the Tariff Act of 1930 (19 U.S.C. 1307) and shall not be 
        entitled to entry at any of the ports of the United States.
            (2) Exception.--The prohibition under paragraph (1) shall 
        not apply to goods, wares, articles, or merchandise if the 
        Commissioner of U.S. Customs and Border Protection finds, by 
        clear and convincing evidence, that the goods, wares, articles, 
        or merchandise were not produced with trafficked labor, convict 
        labor, forced labor, or indentured labor under penal sanctions.
    (b) Sanctions With Respect to Persons That Use North Korean 
Labor.--The President shall, pursuant to the International Emergency 
Economic Powers Act (50 U.S.C. 1701 et seq.), block and prohibit all 
transactions in property and interests in property of a person that the 
President determines mines, produces, or manufactures goods, wares, 
articles, or merchandise prohibited from entry into the United States 
under subsection (a), if such property and interests in property are in 
the United States, come within the United States, or are or come within 
the possession or control of a United States person.
    (c) Trafficked Labor Defined.--In this section, the term 
``trafficked labor'' means labor or services procured through the 
recruitment, harboring, transportation, provision, or obtaining of a 
person through the use of force, fraud, or coercion for the purpose of 
subjection to involuntary servitude, peonage, debt bondage, or slavery.

SEC. 5. MANDATORY DISCLOSURE OF INVESTMENTS IN THE DEMOCRATIC PEOPLE'S 
              REPUBLIC OF KOREA AND OTHER SANCTIONABLE ACTIVITIES.

    (a) In General.--Not later than 270 days after the date of the 
enactment of this Act, the Securities and Exchange Commission shall 
prescribe regulations requiring each issuer to disclose annually, 
beginning with the issuer's first fiscal year that begins after the 
date on which those regulations are prescribed--
            (1) any investments in the Democratic People's Republic of 
        Korea; and
            (2) any other activities that may be subject to sanctions 
        under section 3 or 4.
    (b) Issuer Defined.--In this section, the term ``issuer'' has the 
meaning given that term in section 3(a) of the Securities Exchange Act 
of 1934 (15 U.S.C. 78c(a)).
Example Output:
North Korean Enablers Accountability Act of 2017 This bill directs the President to: (1) impose property-blocking sanctions against the North Korean government, business entities that trade with North Korea, including specified Chinese entities, and affiliated persons or entities; (2) prohibit the opening, and strictly control the maintaining in the United States, of correspondent or payable-through accounts by a foreign financial institution that assisted in the importation, sale, or transfer of North Korean goods or services; and (3) impose specified sanctions against a person that imports, purchases, or transfers goods or services from the North Korean government or from such entities or affiliates. The President may waive the application of these sanctions for humanitarian or national security purposes. The bill prohibits the U.S. entry of goods mined, produced, or manufactured by North Korean labor, and directs the President to apply property-blocking sanctions against a person or entity that mines, produces, or manufactures such prohibited goods. Such prohibition shall not apply if U.S. Customs and Border Protection finds that the goods were not produced with trafficked, convict, forced, or indentured labor.  The Securities and Exchange Commission shall require issuers of stock and other securities to disclose annually any investments in North Korea and activities potentially sanctionable under this bill.